Clinical Trial Update: GORE® CARDIOFORM Septal Occluder Migraine Clinical Study [NA]

View source ↗

Summary

A clinical trial of the GORE CARDIOFORM Septal Occluder for migraine associated with patent foramen ovale has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• GORE CARDIOFORM Septal Occluder

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Migraine, Patent Foramen Ovale | NA | Status: TERMINATED